Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by EbbFlow88on Sep 08, 2021 2:00pm
99 Views
Post# 33825504

RE:RE:BNN Market Call

RE:RE:BNN Market CallChurning is not a bad thing. This base has been building for 6 months getting rid of past shareholders that have been burned. The ones holding on are stronger hands. The longer the base the better.

This has recently showed some strength off of solid earnings. If/when they keep this up it will be a stronger foundation to build on. 

I have been in Cameco since 2017 and it was the same story. Horrible price action for almost a decade and anyone who would mention CCO would be laughed at..."dead money", "too risky", etc.

That base lasted 4 years and now up over 100% for CAGR of over 20%.

Same with natural gas stocks and lumber. 

Buy when no one wants it. That's GUD today and the smart money is building positions.
<< Previous
Bullboard Posts
Next >>